{"concept":[{"code":"AW","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Vermindering gebeurtenis na terugtrekken product"}],"display":"Abatement of event after product withdrawn"},{"code":"BE","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Gebeurtenis trad opnieuw op na herintroductie product"}],"display":"Event recurred after product reintroduced"},{"code":"DR","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Dosis reactie geobserveerd"}],"display":"Dose response observed"},{"code":"EX","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Alternatieve verklaringen voor gebeurtenis beschikbaar"}],"display":"Alternative explanations for the event available"},{"code":"IN","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Gebeurtenis trad op na introductie product"}],"display":"Event occurred after product introduced"},{"code":"LI","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Literatuur vermeldt koppeling van product met gebeurtenis"}],"display":"Literature reports association of product with event"},{"code":"OE","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Optreden van gebeurtenis is bevestigd door objectief bewijs"}],"display":"Occurrence of event was confirmed by objective evidence"},{"code":"OT","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Anders"}],"display":"Other"},{"code":"PL","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Effect geobserveerd wanneer patiënt placebo krijgt"}],"display":"Effect observed when patient receives placebo"},{"code":"SE","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Vergelijkbare gebeurtenissen in verleden voor deze patiënt"}],"display":"Similar events in past for this patient"},{"code":"TC","designation":[{"language":"nl","use":{"code":"display","system":"http://terminology.hl7.org/CodeSystem/designation-usage"},"value":"Toxische niveaus van product gedocumenteerd in bloed of lichaamssappen"}],"display":"Toxic levels of product documented in blood or body fluids"}],"contact":[{"telecom":[{"system":"url","value":"http://hl7.org"}]}],"content":"complete","description":"FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)","experimental":false,"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status","valueCode":"external"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm","valueInteger":0}],"id":"v2-0252","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.18.147"}],"language":"en","meta":{"profile":["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]},"name":"v2.0252","publisher":"HL7, Inc","resourceType":"CodeSystem","status":"active","text":{"div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Causality Observations</p>\r\n<table class=\"grid\"><tr><td><b>Code</b></td><td><b>Description</b></td><td><b>Comment</b></td><td><b>Version</b></td></tr><tr><td>AW<a name=\"AW\"> </a></td><td>Abatement of event after product withdrawn</td><td/><td>added v2.3</td></tr><tr><td>BE<a name=\"BE\"> </a></td><td>Event recurred after product reintroduced</td><td/><td>added v2.3</td></tr><tr><td>DR<a name=\"DR\"> </a></td><td>Dose response observed</td><td/><td>added v2.3</td></tr><tr><td>EX<a name=\"EX\"> </a></td><td>Alternative explanations for the event available</td><td/><td>added v2.3</td></tr><tr><td>IN<a name=\"IN\"> </a></td><td>Event occurred after product introduced</td><td/><td>added v2.3</td></tr><tr><td>LI<a name=\"LI\"> </a></td><td>Literature reports association of product with event</td><td/><td>added v2.3</td></tr><tr><td>OE<a name=\"OE\"> </a></td><td>Occurrence of event was confirmed by objective evidence</td><td/><td>added v2.3</td></tr><tr><td>OT<a name=\"OT\"> </a></td><td>Other</td><td/><td>added v2.3</td></tr><tr><td>PL<a name=\"PL\"> </a></td><td>Effect observed when patient receives placebo</td><td/><td>added v2.3</td></tr><tr><td>SE<a name=\"SE\"> </a></td><td>Similar events in past for this patient</td><td/><td>added v2.3</td></tr><tr><td>TC<a name=\"TC\"> </a></td><td>Toxic levels of product documented in blood or body fluids</td><td/><td>added v2.3</td></tr></table>\r\n</div>","status":"additional"},"title":"v2 Causality Observations","url":"http://terminology.hl7.org/CodeSystem/v2-0252","version":"2.9"}